Simfy Lo: Amida Care P&T Review

P&T Meetings


In September 2018, Amida Care invited me to present at their Pharmacy and Therapeutics Committee Meeting to add single agent doravarine (Pifeltro) and its combination (Delstrigo) to formulary. The formulary recommendation was accepted.

The presentation can be accessed using the link below.